De Novo Antibody Sequencing



September 25, 2023

  • Share
  • The discrimination of leucine and isoleucine has long been the key technical difficulties of de novo antibody sequencing. However, Creative Biolabs just took a massive leap forward into the new era of this field, with unchallenged ability to achieve 100% accuracy in antibody sequencing by precisely distinguishing between leucine and isoleucine, based on the proprietary Database Assisted Shotgun Sequencing (DASS) technology.

    Next-Generation Sequencing

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.